Lack of consensus on anticoagulation after acute ischemic stroke in atrial fibrillation

Results of an internet-based questionnaire revealed a remarkable lack of consensus among US stroke neurologists on the timing of anticoagulation for secondary stroke prevention in patients with acute ischemic stroke due to non-valvular paroxysmal atrial fibrillation. Direct oral anticoagulants were the preferred anticoagulation strategy [1]. Risk of early recurrence of ischemic stroke due to atrial fibrillation may be high, but guidelines of the American Heart Association/American Stroke Association (AHA/ASA) provide imprecise recommendations on the timing and choice of anticoagulant for secondary prevention. A survey assessed current opinions of US board-certified stroke neurologists. In the survey, cases were presented of patients with acute ischemic stroke of varying severity and haemorrhagic transformation following paroxysmal atrial fibrillation. Of 1,239 stroke neurologists surveyed, 238 responded. These were some of the main outcomes: F...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on 30 July, 201915 March, 2021